Shares of Centrus Energy Corp. (LEU) skyrocketed by 6.74% on Thursday, October 18, 2024, following a major announcement from the U.S. Department of Energy (DOE) regarding the production of High-Assay Low-Enriched Uranium (HALEU), a critical fuel for many next-generation nuclear reactor designs.
The surge was fueled by the news that Centrus' subsidiary, American Centrifuge Operating (ACO), secured a lucrative award from the DOE aimed at expanding domestic commercial production of HALEU. ACO was one of only four companies selected for this contract, which has a minimum value of $2 million and a potential maximum value of $2.7 billion for all awardees over a ten-year period.
According to Centrus, ACO will manufacture the centrifuges and supporting equipment exclusively in the United States, relying on domestic engineering and a U.S. supply chain spanning 14 major suppliers across 13 states. This strategic move positions Centrus at the forefront of the emerging HALEU market, capitalizing on the increasing adoption of advanced nuclear reactors by tech giants and the broader push for carbon-free energy sources.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.